secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evolent Health, Inc. (EVH)
CIK:        0001628908
Form:       8-K
Filed at:   2024-12-11T23:59:59+00:00
Accession:  0001628908-24-000117
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evolent Health amends credit agreement adding $250M in new debt facilities
--------------------------------------------------------------------------

- Increased existing ABL revolver by $50M (with $25M funded); new delayed draw term loans of $125M and $75M.
- Interest rates: ABL at SOFR + 4.00% or base + 3.00%; term loans at SOFR + 5.50% or base + 4.50%.
- Maturity is earliest of 5 years from Dec 6, 2024, or 180 days before 2029 convertible notes maturity.
- Borrowing under term loans requires total secured leverage ratio ≤ 2.00:1.00.
- Upfront fees: 1% on ABL commitment; 2% (reducible to 1%) on term loan amounts funded.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628908/000162890824000117/0001628908-24-000117-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628908/000162890824000117/evh-20241206.htm
  HTML page:      https://secwatch.observer/filing/0001628908-24-000117

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer